Literature DB >> 8099149

Management of pre-eclampsia.

C W Redman1, J M Roberts.   

Abstract

Mesh：

Year:  1993        PMID： 8099149     DOI： 10.1016/0140-6736(93)90890-s

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  The management of pregnancy in hypertensive patients.

Authors:  R D Tunbridge
Journal:  Postgrad Med J       Date:  1994-11       Impact factor: 2.401

Review 2.  Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?

Authors:  S M Khedun; B Maharaj; J Moodley
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

3.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

Review 4.  Maternal preeclampsia and neonatal outcomes.

Authors:  Carl H Backes; Kara Markham; Pamela Moorehead; Leandro Cordero; Craig A Nankervis; Peter J Giannone
Journal:  J Pregnancy       Date:  2011-04-04

5.  Obstetric physicians: are they needed? The workload of a medical complications in pregnancy clinic.

Authors:  C Nelson-Piercy; M J Peek; M D Swiet
Journal:  J R Coll Physicians Lond       Date:  1996 Mar-Apr

6.  Protective effect of dexmedetomidine on kidney injury of parturients with preeclampsia undergoing cesarean section: a randomized controlled study.

Authors:  Qing-Lin Zhang; Lei Wang; Ming-Jun Xu; Tian-Long Wang
Journal:  Biosci Rep       Date:  2019-05-03       Impact factor: 3.840

7.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.

Authors:  Edgardo Abalos; Lelia Duley; D Wilhelm Steyn; Celina Gialdini
Journal:  Cochrane Database Syst Rev       Date:  2018-10-01

8.  Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.

Authors:  Corine M Koopmans; Denise Bijlenga; Jan G Aarnoudse; Erik van Beek; Dick J Bekedam; Paul P van den Berg; Jan M Burggraaff; Erwin Birnie; Kitty W M Bloemenkamp; Addi P Drogtrop; Arie Franx; Christianne J M de Groot; Anjoke J M Huisjes; Anneke Kwee; Saskia le Cessie; Aren J van Loon; Ben W J Mol; Joris A M van der Post; Frans J M E Roumen; Hubertina C J Scheepers; Marc E A Spaanderman; Rob H Stigter; Christine Willekes; Maria G van Pampus
Journal:  BMC Pregnancy Childbirth       Date:  2007-07-27       Impact factor: 3.007

9.  HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients.

Authors:  Yasser S Basmaeil; Dana Algudiri; Reem Alenzi; Abdullah Al Subayyil; Ayodele Alaiya; Tanvir Khatlani
Journal:  Stem Cell Res Ther       Date:  2020-01-21       Impact factor: 6.832
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.